Biology can be programmed like software. That's not a metaphor — it's literally what we do.

Tom Knight wrote the foundational paper on synthetic biology at MIT. We're his commercial legacy.

TSMC manufactures chips to spec. Ginkgo manufactures organisms to spec. Same model, different substrate.

Every organism we engineer adds to our codebase. The platform gets better with every project.

We went from $24 billion valuation to $1 billion. The science is real. The revenue timeline wasn't.

We were the first biotech in Y Combinator. People thought we were insane. We raised $2.8 billion.